Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus

References

• Benseler SM, Silverman ED. Systemic lupus erythematosus. Pediatr Clin North Am 2005; 52: 443–467, vi
   PubMedGoogle Scholar
• Sawalha AH, Harley JB. Antinuclear autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 2004; 16: 534–540
   PubMed Web of Science ®Google Scholar
• Hardin JA. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1986; 29: 457–460
   PubMed Web of Science ®Google Scholar
• James JA, Scofield RH, Harley JB. Lupus humoral autoimmunity after short peptide immunization. Ann N Y Acad Sci 1997; 815: 124–127
   Google Scholar
• Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol 1993; 23: 1146–1152
   Google Scholar
• Petersen J, Rhodes G, Roudier J, Vaughan JH. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1990; 33: 993–1000
   PubMedGoogle Scholar
• McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005; 11: 85–89
   PubMed Web of Science ®Google Scholar
• Incaprera M, Rindi L, Bazzichi A, Garzelli C. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin Exp Rheumatol 1998; 16: 289–294
   Google Scholar
• Newkirk MM, van Venrooij WJ, Marshall GS. Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection. Arthritis Res 2001; 3: 253–258
   PubMedGoogle Scholar
• Deas JE, Liu LG, Thompson JJ, Sander DM, Soble SS, Garry RF, Gallaher WR. Reactivity of sera from systemic lupus erythematosus and Sjogren's syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen. Clin Diagn Lab Immunol 1998; 5: 181–185
   PubMedGoogle Scholar
• Perl A, Colombo E, Dai H, Agarwal R, Mark KA, Banki K, Poiesz BJ, Phillips PE, Hoch SO, Reveille JD, et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 1995; 38: 1660–1671
   PubMed Web of Science ®Google Scholar
• James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100: 3019–3026
   PubMed Web of Science ®Google Scholar
• Harley JB, James JA. Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagers. Arthritis Rheum 1999; 42: 1782–1783
   PubMedGoogle Scholar
• James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, Harley JB. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2000; 44: 1122–1126
   Google Scholar
• James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995; 181: 453–461
   PubMedGoogle Scholar
• Arbuckle MR, Reichlin M, Harley JB, James JA. Shared early autoantibody recognition events in the development of anti-Sm B/B′ in human lupus. Scand J Immunol 1999; 50: 447–455
   PubMed Web of Science ®Google Scholar
• McClain M, Poole B, Bruner B, Kaufman K, Harley J, James J. An altered immune response to Epstein-Barr virus nuclear antigen-1 (EBNA-1) in pediatric systemic lupus erythematosus. Arthritis Rheum, In Press
   Google Scholar
• Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, Clair EW, St, Gilkeson GS, Pandey JP. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 2005; 52: 1148–1159
   PubMedGoogle Scholar
• Chen CJ, Lin KH, Lin SC, Tsai WC, Yen JH, Chang SJ, Lu SN, Liu HW. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: Case control studies. J Rheumatol 2005; 32: 44–47
   PubMed Web of Science ®Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–1533
   PubMed Web of Science ®Google Scholar
• Lake P, Mitchison NA. Regulatory mechanisms in the immune response to cell-surface antigens. Cold Spring Harb Symp Quant Biol 1977; 41(Pt 2)589–595
   Google Scholar
• Mamula MJ, Janeway CA, Jr. Do B cells drive the diversification of immune responses?. Immunol Today 1993; 14: 151–152
   PubMedGoogle Scholar
• Roth R, Nakamura T, Mamula MJ. B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells. J Immunol 1996; 157: 2924–2931
   Google Scholar
• Craft J, Fatenejad S. Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum 1997; 40: 1374–1382
   PubMedGoogle Scholar
• Fisher DE, Reeves WH, Wisniewolski R, Lahita RG, Chiorazzi N. Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum 1985; 28: 1348–1355
   PubMed Web of Science ®Google Scholar
• Topfer F, Gordon T, McCluskey J. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci USA 1995; 92: 875–879
   Google Scholar
• Dumortier H, Monneaux F, Jahn-Schmid B, Briand JP, Skriner K, Cohen PL, Smolen JS, Steiner G, Muller S. B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus mice. J Immunol 2000; 165: 2297–2305
   Google Scholar
• Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 1993; 91: 1687–1696
   PubMed Web of Science ®Google Scholar
• Stunz LL, Busch LK, Munroe ME, Sigmund CD, Tygrett LT, Waldschmidt TJ, Bishop GA. Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture. Immunity 2004; 21: 255–266
   PubMed Web of Science ®Google Scholar
• Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 1993; 90: 8479–8483
   PubMed Web of Science ®Google Scholar
• Suzuki T, Tahara H, Narula S, Moore KW, Robbins PD, Lotze MT. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J Exp Med 1995; 182: 477–486
   PubMed Web of Science ®Google Scholar
• Scofield JI. Epitope mapping of the Ro/SSA60KD autoantigen reveals disease-specific antibody-binding profiles. Eur J Clin Invest 1996; 26: 514–521, 1996, AR 1992
   Google Scholar
• Routsias JG, Tzioufas AG, Sakarellos-Daitsiotis M, Sakarellos C, Moutsopoulos HM. Epitope mapping of the Ro/SSA60KD autoantigen reveals disease-specific antibody-binding profiles. Eur J Clin Invest 1996; 26: 514–521
   Google Scholar
• Scofield AN, Kurien BT, Gordon TP, Scofield RH. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjogren's syndrome?. Lupus 2001; 10: 547–553
   Google Scholar
• Tseng CE, Chan EK, Miranda E, Gross M, Di Donato F, Buyon JP. The 52 kd protein as a target of intermolecular spreading of the immune response to components of the SS-A/Ro-SS-B/La complex. Arthritis Rheum 1997; 40: 936–944
   PubMedGoogle Scholar
• McClain MT, Scofield RH, Kurien BT, Gross TF, James JA. Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE. Scand J Immunol 2002; 56: 399–407
   PubMed Web of Science ®Google Scholar
• Scofield RH, Henry WE, Kurien BT, James JA, Harley JB. Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60 kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J Immunol 1996; 156: 4059–4066
   Google Scholar
• Scofield RH, Kurien BT, Ganick S, McClain MT, Pye Q, James JA, Schneider RI, Broyles RH, Bachmann M, Hensley K. Modification of lupus-associated 60 kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic Biol Med 2005; 38: 719–728
   PubMed Web of Science ®Google Scholar
• Deshmukh US, Lewis JE, Gaskin F, Kannapell CC, Waters ST, Lou YH, Tung KS, Fu SM. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J Exp Med 1999; 189: 531–540
   Google Scholar
• Deshmukh US, Lewis JE, Gaskin F, Dhakephalkar PK, Kannapell CC, Waters ST, Fu SM. Ro60 peptides induce antibodies to similar epitopes shared among lupus-related autoantigens. J Immunol 2000; 164: 6655–6661
   Google Scholar
• McCluskey J, Farris AD, Keech CL, Purcell AW, Rischmueller M, Kinoshita G, Reynolds P, Gordon TP. Determinant spreading: Lessons from animal models and human disease. Immunol Rev 1998; 164: 209–229
   PubMedGoogle Scholar
• Petrovas CJ, Vlachoyiannopoulos PG, Tzioufas AG, Alexopoulos C, Tsikaris V, Sakarellos-Daitsiotis M, Sakarellos C, Moutsopoulos HM. A major Sm epitope anchored to sequential oligopeptide carriers is a suitable antigenic substrate to detect anti-Sm antibodies. J Immunol Methods 1998; 220: 59–68
   Google Scholar
• James JA, Harley JB. Linear epitope mapping of an Sm B/B′ polypeptide. J Immunol 1992; 148: 2074–2079
   PubMedGoogle Scholar
• James JA, Harley JB. B-cell epitope spreading in autoimmunity. Immunol Rev 1998; 164: 185–200
   PubMedGoogle Scholar
• James JA, Harley JB. A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice. J Immunol 1998; 160: 502–508
   PubMed Web of Science ®Google Scholar
• Mason LJ, Timothy LM, Isenberg DA, Kalsi JK. Immunization with a peptide of Sm B/B′ results in limited epitope spreading but not autoimmune disease. J Immunol 1999; 162: 5099–5105
   Google Scholar
• Vlachoyiannopoulos PG, Petrovas C, Tzioufas AG, Alexopoulos C, Tsikaris V, Guialis A, Nakopoulou L, Sakarellos-Daitsiotis M, Sakarellos C, Davaris P, Moutsopoulos HM. No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs). J Autoimmun 2000; 14: 53–61
   Google Scholar
• Marchini B, Dolcher MP, Sabbatini A, Klein G, Migliorini P. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. J Autoimmun 1994; 7: 179–191
   Google Scholar
• Brahms H, Raymackers J, Union A, de Keyser F, Meheus L, Luhrmann R. The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J Biol Chem 2000; 275: 17122–17129
   PubMed Web of Science ®Google Scholar
• James JA, Mamula MJ, Harley JB. Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRL lpr/lpr antibodies. Clin Exp Immunol 1994; 98: 419–426
   PubMedGoogle Scholar
• Riemekasten G, Marell J, Trebeljahr G, Klein R, Hausdorf G, Haupl T, Schneider-Mergener J, Burmester GR, Hiepe F. A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J Clin Invest 1998; 102: 754–763
   PubMed Web of Science ®Google Scholar
• Sundar K, Jacques S, Gottlieb P, Villars R, Benito ME, Taylor DK, Spatz LA. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun 2004; 23: 127–140
   PubMedGoogle Scholar
• Tsao BP. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004; 16: 513–521
   PubMed Web of Science ®Google Scholar
• Nath S, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004; 16: 794–800
   PubMedGoogle Scholar
• McClain MT, Rapp EC, Harley JB, James JA. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J Med Virol 2003; 70: 253–257
   Google Scholar
• Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH, Cho CS, Kim HY, Lee WK, Lee SK. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 2004; 6: R295–R302
   PubMed Web of Science ®Google Scholar
• Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 2004; 172: 1287–1294
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985; 314: 537–539
   PubMed Web of Science ®Google Scholar
• Doyle HA, Yan J, Liang B, Mamula MJ. Lupus autoantigens: Their origins, forms, and presentation. Immunol Res 2001; 24: 131–147
   Google Scholar